News and Views
Nature Immunology 9, 835 - 836 (2008)
doi:10.1038/ni0808-835
Arrestin NK cell cytotoxicity
Yenan T Bryceson1 & Hans-Gustaf Ljunggren2
-
Yenan T. Bryceson is at the Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, S-14186 Stockholm, Sweden and at the Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland 20852, USA.
e-mail: yenan.bryceson@gmail.com -
Hans-Gustaf Ljunggren is at the Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, S-14186 Stockholm, Sweden.
e-mail: hans-gustaf.ljunggren@ki.se
Abstract
A key regulator of the balance of signals that activate effector mechanisms versus those that restrain them, 
-arrestin 2 mediates the inhibition of natural killer cell cytotoxicity.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
NK cell tolerance: revisiting the central dogmaNature Immunology News and Views (01 Sep 2005)
Having it both ways: MHC recognition in cis and transNature Immunology News and Views (01 Mar 2004)
See all 4 matches for News And ViewsRESEARCH
An essential function for β-arrestin 2 in the inhibitory signaling of natural killer cellsNature Immunology Article (01 Aug 2008)
Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-EThe EMBO Journal Article (02 Aug 1999)
See all 10 matches for Research
